CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Czechia

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Fakultni nemocnice Brno, Brno

  Registry updated 2026-11-03

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Brno · Prague

  Registry updated 2026-10-27

• NCT07091630

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Fakultni nemocnice Brno, Brno

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  Fakultni nemocnice Brno, Brno · Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove · Fakultni nemocnice Ostrava, Ostrava · Nemocnice Pardubickeho kraje a.s., Pardubice · Vseobecna Fakultni Nemocnice V Praze, Prague 2

  Registry updated 2026-10-19

• NCT07540221

  A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  Trial Treatment · Phase 3 · Grifols Therapeutics LLC

  Hradec Králové

  Registry updated 2026-10-09

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error